NGM
Invesco’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,936
| Closed | -$20.6K | – | 4016 |
|
|
2024
Q1 | $20.6K | Sell |
12,936
-763
| -6% | -$1.21K | ﹤0.01% | 3823 |
|
|
2023
Q4 | $11.8K | Sell |
13,699
-14,823
| -52% | -$12.7K | ﹤0.01% | 3805 |
|
|
2023
Q3 | $30.5K | Buy |
28,522
+5,589
| +24% | +$5.98K | ﹤0.01% | 3813 |
|
|
2023
Q2 | $59.4K | Buy |
22,933
+1,695
| +8% | +$4.39K | ﹤0.01% | 3789 |
|
|
2023
Q1 | $86.7K | Buy |
21,238
+1,793
| +9% | +$7.32K | ﹤0.01% | 3695 |
|
|
2022
Q4 | $97.6K | Sell |
19,445
-42,458
| -69% | -$213K | ﹤0.01% | 3809 |
|
|
2022
Q3 | $809K | Buy |
61,903
+7,923
| +15% | +$104K | ﹤0.01% | 2992 |
|
|
2022
Q2 | $693K | Sell |
53,980
-1,258
| -2% | -$16.2K | ﹤0.01% | 3152 |
|
|
2022
Q1 | $842K | Buy |
55,238
+3,313
| +6% | +$50.5K | ﹤0.01% | 3118 |
|
|
2021
Q4 | $920K | Buy |
51,925
+2,730
| +6% | +$48.4K | ﹤0.01% | 3078 |
|
|
2021
Q3 | $1.03M | Buy |
49,195
+34,204
| +228% | +$719K | ﹤0.01% | 3070 |
|
|
2021
Q2 | $296K | Sell |
14,991
-19,775
| -57% | -$390K | ﹤0.01% | 3607 |
|
|
2021
Q1 | $1.01M | Sell |
34,766
-42,412
| -55% | -$1.23M | ﹤0.01% | 3032 |
|
|
2020
Q4 | $2.34M | Buy |
77,178
+33,161
| +75% | +$1M | ﹤0.01% | 2551 |
|
|
2020
Q3 | $700K | Buy |
44,017
+6,185
| +16% | +$98.4K | ﹤0.01% | 2965 |
|
|
2020
Q2 | $747K | Buy |
+37,832
| New | +$747K | ﹤0.01% | 2929 |
|